Hypertrophic cardiomyopathy: pathological features and molecular pathogenesis

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder with diverse presentations.
• It is a leading cause of sudden death in young athletes and significant morbidity/mortality in all age groups.
• Understanding the molecular basis of HCM is crucial for developing effective treatments.

Purpose of the Study:

• To review the pathological features of hypertrophic cardiomyopathy.
• To summarize the rapidly evolving molecular genetics of HCM.
• To enhance the understanding of this complex cardiac disorder.

Main Methods:

• Literature review of genetic and pathological studies on HCM.
• Synthesis of current knowledge on sarcomeric protein gene mutations.
• Analysis of diagnostic challenges and evolving treatment strategies.

Main Results:

• Identification of numerous mutations in sarcomeric protein genes causing HCM.
• Elucidation of the heterogeneous genotypic and phenotypic spectrum of the disease.
• Recognition of HCM as a significant cause of cardiac morbidity and mortality.

Conclusions:

• HCM is a genetically driven disease with complex manifestations.
• Advances in molecular genetics are improving the understanding and diagnosis of HCM.
• Further research into molecular mechanisms is essential for targeted therapies.